Cardinal Strategic Wealth Guidance Agenus Inc Transaction History

Cardinal Strategic Wealth Guidance

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$0.63 - $1.14 $126,000 - $227,999	200,000 Added 28.16%	910,265 $755,000
Q3 2023 Oct 31, 2023	BUY	$1.12 - $1.88 $112,000 - $188,000	100,000 Added 16.39%	710,265 $802,000
Q2 2022 Jul 27, 2022	BUY	$1.3 - $2.64 $76,700 - $155,760	59,000 Added 10.7%	610,265 $1.18 Million
Q1 2022 Apr 26, 2022	BUY	$2.35 - $3.47 $223,583 - $330,142	95,142 Added 20.86%	551,265 $1.36 Million
Q4 2021 Jan 26, 2022	BUY	$2.92 - $5.74 $876,000 - $1.72 Million	300,000 Added 192.16%	456,123 $1.47 Million
Q3 2021 Nov 05, 2021	SELL	$4.98 - $6.63 $747,000 - $994,500	-150,000 Reduced 49.0%	156,123 $820,000
Q2 2021 Jul 27, 2021	BUY	$2.56 - $5.49 $307 - $658	120 Added 0.04%	306,123 $1.68 Million
Q1 2021 Apr 29, 2021	BUY	$2.69 - $5.25 $26,900 - $52,500	10,000 Added 3.38%	306,003 $832,000
Q3 2020 Oct 21, 2020	SELL	$2.98 - $5.2 $104,300 - $182,000	-35,000 Reduced 10.57%	296,003 $1.18 Million
Q2 2020 Aug 12, 2020	SELL	$2.29 - $4.24 $19,808 - $36,676	-8,650 Reduced 2.55%	331,003 $1.3 Million
Q1 2020 Apr 27, 2020	BUY	$1.92 - $4.39 $52,252 - $119,473	27,215 Added 8.71%	339,653 $832,000
Q4 2019 Feb 05, 2020	BUY	$2.41 - $4.4 $752,975 - $1.37 Million	312,438 New	312,438 $1.27 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Cardinal Strategic Wealth Guidance, based on Form 13F filings with the SEC.

Stay updated on Cardinal Strategic Wealth Guidance with notifications on news.